Associated Papers
Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic BRCA1 Variant in Ovarian Cancer Cases Clinically Negative for Pathogenic BRCA1 and BRCA2 Variants.
Alenezi WM et al.
Genes, 2022
35456503 (PubMed )
Supplement: genes-13-00697-s001.zip › genes-1650796-supplementary.xlsx › Suppl_Table_S3
BRCA1/BRCA2 mutation spectrum analysis in South Asia: a systematic review.
Kharel S et al.
The Journal of International Medical Research, 2022
35000471 (PubMed )
Supplement: sj-pdf-3-imr-10.1177_03000605211070757.pdf
Hybrid curation of gene-mutation relations combining automated extraction and crowdsourcing.
Burger JD et al.
Database : the Journal of Biological Databases and Curation, 2014
25246425 (PubMed )
Supplement: supp_bau094_Appendix_D_v30.docx
A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.
Karami F et al.
Biomed Research International, 2013
BRCA1 And BRCA2 analysis of Argentinean breast/ovarian cancer patients selected for age and family history highlights a role for novel mutations of putative south-American origin.
Solano AR et al.
Springerplus, 2012
Identification of novel intronic BRCA1 variants of uncertain significance in a Thai hereditary breast cancer family.
Ratanaphan A et al.
Journal of Genetics, 2011
Novel sequence variants and a high frequency of recurrent polymorphisms in BRCA1 gene in Sri Lankan breast cancer patients and at risk individuals.
De Silva W et al.
Bmc Cancer, 2008
Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.
Saxena S et al.
Bmc Medical Genetics, 2006
Select a paper to view details